Prevalence and risk factors of abdominal aortic aneurysm among over 65 years old population in Lublin, Poland by Tkaczyk, Jedrzej et al.
1www.journals.viamedica.pl/acta_angiologica
Acta Angiol
Vol. 25, No. 1, pp. 1–6
Doi: 10.5603/AA.2019.0001
Copyright © 2019 Via Medica
ISSN 1234–950X
www.journals.viamedica.pl/acta_angiologica
ORIGINAL ARTICLE
Address for correspondence:  Jędrzej Tkaczyk, Students Scientific Group at the Department of Vascular Surgery and Angiology,  
Medical University of Lublin, Poland, e-mail: jedrzej.tkaczyk@gmail.com
Prevalence and risk factors of abdominal  
aortic aneurysm among over 65 years old  
population in Lublin, Poland
Jędrzej Tkaczyk1, Stanisław Przywara2, Michał Terpiłowski1, Klaudia Brożyna1,  
Marek Iłżecki2, Piotr Terlecki2, Tomasz Zubilewicz2
1Students Scientific Group at the Department of Vascular Surgery and Angiology, Medical University of Lublin, Poland 
2Department of Vascular Surgery and Angiology, Medical University of Lublin, Poland
Abstract
Introduction: Abdominal aortic aneurysm (AAA) is a disease exceptionally well suited to screening. Ultra-
sound-based screening meets all criteria for a screening program according to the WHO, and there is a large 
evidence supporting its usefulness. Risk factors, mentioned in the available literature, associated with aneurysm 
formation are advanced age, male gender, tobacco smoking, hypertension, atherosclerotic disease and family 
or personal history of aortic aneurysms.
The aim of the study was to evaluate the incidence of abdominal aortic aneurysms in the population of men 
and women older than 65 years, in Lublin, Poland and to identify the correlation between risk factors and the 
AAA incidence.
Material and methods: A single-center screening study, for men and women older than 65-years was con-
ducted in Lublin, Poland in May 2018. Patients underwent basic screening ultrasound with measurement of the 
diameter of abdominal aorta and iliac arteries. Each patient completed anonymous questionnaire to investigate 
risk factors of developing AAA. 
Results: 1032 patients, aged 65–91 (median age 71.37) were examined. 569 of them were women and 
463 men. 27 aortic aneurysms were detected — 7 in a group of women and 20 in a group of men. The total 
incidence rate of AAA in our study was 2.62%; 1,23% in women and 4,32% in men. Male gender, cigarette 
smoking, coronary artery disease and a history of myocardial infarction all appeared to be major risk factors 
of AAA, with relative risk ranging from 2,75 to 4.53. The median diameter of the abdominal aorta was 19.24 
mm and varied in groups of patients with different risk factors.
Conclusions: The estimated prevalence of AAA in the screened population is within the range of the values 
reported in previous publications, however, it may confirm a trend of declining prevalence of AAA showed in 
some recent studies. The presented study confirms the correlation between the AAA and its major risk factors 
(male sex, smoking cigarettes, coronary artery disease and history of myocardial infarct) as well as a weak 
association between AAA and hypertension and a negative correlation with diabetes. 
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Introduction
Abdominal aortic aneurysm (AAA) is defined as dilata-
tion of aorta diameter exceeding 30 mm, or 1.5 times 
its original size or normal [1]. The aortic segment, most 
commonly affected with AAA is the one below the ostia 
of renal arteries (infrarenal AAA). Only 5% of AAAs 
involves renal or visceral arteries [2]. The pathogenesis 
of AAA is mainly associated with atherosclerosis, which 
leads to a progressive weakening of the aortic wall [3]. 
AAAs demonstrate extensive structural remodelling, 
characterized by degeneration of extracellular matrix, 
destruction of elastic lamina and reduction of vascular 
smooth muscle cells (VSMCs) [4]. The involvement of 
inflammation in the pathogenesis of AAAs has been well 
recognized through the years. Inflammatory cells are re-
sponsible for the destruction of extracellular matrix and 
apoptosis of VSMCs, and are proposed to play a huge 
role in the development of AAA. The most commonly 
found in AAA tissues are CD4-positive lymphocytes or 
T cells, followed by B lymphocytes [5]. 
Risk factors, associated with aneurysm formation 
are advanced age, male gender, tobacco smoking, 
hypertension, atherosclerotic disease and family or 
personal history of aortic aneurysms [6, 7]. Dyslipi-
demia seems to be a weaker risk factor, while diabetic 
patients are at decreased risk for AAA [8]. According 
to available screening studies, the estimated prevalence 
of AAA ranges from 4.1% to 14.2% in men and from 
0.35% to 6.2% in women [7]. However, some recent 
studies suggest a decrease in AAA prevalence: Svensjo 
et al. showed that the total prevalence of AAA in 
a population of 65-year-old Swedish men was 2.2%. 
A lower-than-expected prevalence of AAA, presented 
in this study, was probably caused by the observed 
reduced exposure to risk factors, especially smoking 
cigarettes [9]. 
In a natural history of AAA there is a long period of 
asymptomatic, subclinical increase in the diameter of 
the aneurysm, estimated at < 1–6 mm/year [10, 11]. 
The diameter progression depends on genetic and envi-
ronmental factors — among which continued smoking 
and baseline diameter are the strongest factors for a 
rapid growth [11]. The risk of rupture rises with AAA 
maximal diameter and is higher in women than in men 
at similar diameters [1]. The estimated risk of death 
before the admission to the hospital in patients with 
AAA rupture is greater than 50%, and 30–50% of 
those who were taken to the hospital and underwent 
aortic repair, would die during the postoperative period 
[12,13]. The most effective therapy to prevent death 
from aortic rupture is elective AAA repair [2]. 
AAA is a disease exceptionally well suited to screening 
[13]. Ultrasound-based screening meets all criteria for 
screening programs according to the WHO, and there is 
substantial evidence supporting the usefulness of screen-
ing to detect AAA and thus reducing the risk of a death 
from AAA rupture in asymptomatic patients [13, 14]. 
There have been four large randomized controlled trials 
(RCT) between 1988 and 1999, that randomized male 
populations to ultrasound-based screening or no screen-
ing for AAA [15–18]. In these studies, a 40% reduction 
in AAA related death has been demonstrated [19]. 
Moreover, the largest RCT — The Multicentre Aneu-
rysm Screening Study, demonstrated a 3% reduction 
in all-cause mortality after 13 years’ follow up [15]. 
The studies, mentioned above, were the basis to start 
national screening programs in Sweden, the UK and 
the USA [20]. 
The purpose of the study was to evaluate the inci-
dence of abdominal aortic aneurysms in the population 
of men and women older than 65 years in Lublin, Poland 
and to identify the correlation between risk factors and 
the AAA incidence.
Material and methods
Single-center, screening and prospective study, for 
men and women older than 65-years was conducted in 
Lublin, Poland in May 2018. Patients underwent colour 
Doppler ultrasound assessment and measurements of 
the diameter of the abdominal aorta (single measure-
ment, in the segment below renal arteries) and iliac 
arteries. Each patient completed an anonymous ques-
tionnaire, regarding possible risk factors of developing 
AAA. Statistical analysis of the data was performed using 
the software Microsoft Excel, and STATISTICA 13.1. 
A p-value ≤ 0.05 was considered as statistically signifi-
cant. Relative risk assessment was used.
Results
1032 patients, aged 65–91 (median age 71.37) un-
derwent a social media call for ultrasound screening 
examination to detect AAA. 569 of them were women 
and 463 men (Table 1). 27 aortic aneurysms (aortic 
diameter > 30 mm) were detected — 7 in a group of 
women and 20 in a group of men. The total incidence 
rate of AAA was 2.62%. The incidence rate in women 
was 1.23% and in men 4.32%. 
The most common concomitant disease in the in-
vestigated population was hypertension — 631 patients 
(61.14%). 206 patients (19.96%) had coronary artery 
disease (CAD), and 201 patients suffered from diabetes 
(19.48%). 118 of them (12.98%) admitted to smoke 
cigarettes. Among all of the risk factors history of myo-
cardial infarction (MI) showed the strongest association 
with AAA; relative risk (RR) = 3.51. Prevalence of AAA in 
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a group of patients who had earlier a MI was 8.33%, and 
only 1.84% for patients with no history of MI (Table 2). 
The second highest RR of developingAAA was observed 
for the male gender, comparing to women (RR = 3.36). 
The other risk factors that were associated with 
a higher risk of developing AAA were: smoking cigarettes 
(RR = 3.36) and CAD (RR = 2.75). Hypertension was 
not connected with a significant increase in the preva-
lence of AAA (RR = 1.08), while diabetes appeared to 
be a potential factor decreasing the risk of developing 
AAA (RR = 0.38).
Among the patients with the AAA, 33,3% were 
smokers, comparing to only 6,23% in a population 
without AAA (p = 0.001985) (Table 3). The other risk 
factors that were more often in patients with AAA 
were: male sex (74.07% vs. 44.08%; p = 0.001985), 
CAD (40.74% vs. 19.40%; p = 0.008274) and history 
of MI (25.93% vs. 8.66%; p = 0.000407). All of these 
differences were statistically significant (p < 0.05). 
Hypertension was only slightly more often present 
in a group of patients with AAA (62.96%) than in 
a group without AAA (61.09%); p = 0.848114, and this 
difference was not statistically significant (p > 0.05). On 
the contrary, diabetes was more frequent in a group 
without AAA, than with AAA (19.80% vs. 7.41%; p = 
0.11577), however this difference was also not statis-
tically significant (p > 0.05). 
The median diameter of the aorta was 19.24 mm, 
right iliac artery 10.84 mm and left iliac artery 10.90 
mm. The median diameter of aorta varied in groups 
of patients with different risk factors (Table 4), and it 
was the highest (22.26 mm) in group of patients with a 
history of MI, which was 15,7% more than the average 
diameter (19.24 mm) in an investigated group. On the 
contrary, the lowest diameter was registered in a group 
of patients with diabetes (18,35 mm — 4,63% less than 
the average for the investigated population). 
Most of the AAAs (75%) detected during the study 
were small — less than 45 mm (Table 5). AAAs with 
the diameter between 45 and 54 mm were observed in 
Table 1. Demographic data of the investigated population
Gender Number of Patients Age Total number of patients
Minimum Average Maximum
Females 569 65 70.97 89
1032
Males 463 65 71.91 91
Table 2. Risk of developing AAA in groups of patients with or without risk factors
Risk factor Prevalence Relative risk (RR)
Yes No
Smoking 6.72% 2% 3.36
Hypertension 2.69% 2.49% 1.08
Male sex 4.32% 1.23% 3.51
Coronary artery disease 5.34% 1.94% 2.75
Diabetes 1.13% 3.01% 0.38
History of myocardial infarct 8.33% 1.84% 4.53
Table 3. Prevalence of risk factor in patients with or without AAA
Risk factor Patients with AAA Patients without AAA p-value
Male sex 74.07% 44.08% 0.001985
Smoking 33.33% 6.23% 0.002257
Hypertension 62.96% 61.09% 0.848114
Diabetes 7.41% 19.80% 0.11577
Coronary artery disease 40.74% 19.40% 0.008274
History of myocardial infarct 25.93% 8.66% 0.000407
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5 patients, which stated for 18.52%. Aneurysms with 
the diameter equal or exceeding 55 mm were detected 
only in 2 patients (7.42%). 
Discussion
The study was conducted on the population of Lublin 
Voivodeship - a province, located in a southeastern 
Poland. It covers an area of 25,155 square kilometres, 
and the population is estimated at 2,113 million people. 
The screening study took place in Lublin - the biggest 
city of the region (population estimated at 342,039 
people). A screened group consisted mainly of citizens 
of Lublin, and nearest towns and villages. 
The estimated prevalence of AAA in a presented 
population (4.32% in men and 1,23% in women) 
remains within the range of the values reported in 
previous publications [7]. Four biggest RCTs reported 
the prevalence of AAA in male populations at the level 
from 4% to 7.2% [15–18], however, some recent 
studies suggested changing epidemiology of AAA. The 
screening prevalence rates of 1.1–1.7% have been 
recently reported [9, 21]. Our study seems to confirm 
that trend. 
The presented study confirms that male sex, cig-
arette smoking, coronary artery disease and a history 
of myocardial infarction are all major risk factors for 
screening-detected AAA, with RR ranging from 2,75 to 
4.53. Interestingly, though hypertension was the most 
frequent risk factor in a presented population, it did not 
appear to have a strong association with AAA (RR = 1.08). 
Patients with diabetes seemed to have the lower risk 
of developing AAA (RR = 0.38). Similar correlations 
have been previously shown in earlier studies [7, 22]. 
A similar study, held in Poland from 2009 to 2011 in 
the Kuyavian-Pomeranian Province by Jawien et al. [23] 
showed that the prevalence of AAA in the population of 
men aged 60 years and older was 6.0%, which is higher 
than in our study. However, in this study, the prevalence 
of smoking cigarettes — one of the main risk factor of 
AAA — was also very high (55%). The distribution of 
the detected AAAs according to the maximum diameter 
was similar to the one observed in our study [23]. 
An inverse association between diabetes mellitus 
and prevalence of AAA was shown already in previous 
studies [6, 7, 24], as well as the slower progression 
rates of AAAs in diabetic patients when compared to 
patients without diabetes [25, 26]. Also, the results 
of meta-analysis of 11 studies, where the prevalence 
of DM in patients with AAAs ranged between 6 and 
14%, while in the absence of AAAs it was between 
17 and 36% [27], correspond with our findings 
(7.41% in patients with AAA; 19.8% in patients 
without AAA). However, the pathophysiological 
mechanisms for this negative relationship are still 
far from being defined [28]. The possible hypothesis 
includes increased arterial wall matrix formation via 
advanced glycation of end products; suppression of 
plasmin and reduction of levels and activity of matrix 
metalloproteinases MMP-2 and MMP-9; diminished 
aortic wall infiltration by macrophages, elastolysis 
and neovascularization [28–30]. 
Table 4. The median diameter of abdominal aorta in groups of patients with or without different risk factors
Risk factor The median diameter of aorta (in mm)
Yes No
Male sex 21.20 17.72
Smoking 20.14 19.11
Hypertension 19.42 18.99
Diabetes 18.35 19.42
Coronary artery disease 20.64 18.93
History of myocardial infarct 22.26 18.95
Table 5. Distribution of the detected abdominal aortic aneurysms (AAAs) according to the maximum diameter
Maximum diameter of AAA (in mm) No. of patients with AAA AAA (%)
30–44 20 74.07
45–54 5 18.52
55 and more 2 7.41
Total 27 100
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Conclusions
Based on the obtained results, it is possible to state the 
following conclusions:
1. The prevalence of the AAAs in a population of > 65 
years old people in Lublin, Poland is within the range 
of the values reported previously in the literature. 
2. Main risk factors associated with developing of AAA 
are constant with literature data and include male 
sex, smoking cigarettes, coronary artery disease and 
history of myocardial infarct.
3. Hypertension did not show a strong association with 
developing AAA.
4. The risk of developing of AAA appeared to be lower 
in patients with diabetes. The median aorta diameter 
of patients with AAA and diabetes was 4.63% lower 
than in a group without diabetes.
5. Prevalence of primary AAA risk factors: smoking 
cigarettes, CAD, history of MI, male sex was higher 
in a group with AAA than in a group without AAA. 
These differences were statistically significant.
6. Median aorta diameter in patients with risk factors 
or AAA development was higher than in patients 
without risk factors.
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